These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22432691)

  • 21. Controlled release of drugs in electrosprayed nanoparticles for bone tissue engineering.
    Jayaraman P; Gandhimathi C; Venugopal JR; Becker DL; Ramakrishna S; Srinivasan DK
    Adv Drug Deliv Rev; 2015 Nov; 94():77-95. PubMed ID: 26415888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue-engineered matrices as functional delivery systems: adsorption and release of bioactive proteins from degradable composite scaffolds.
    Cushnie EK; Khan YM; Laurencin CT
    J Biomed Mater Res A; 2010 Aug; 94(2):568-75. PubMed ID: 20198692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Affinity-based drug delivery systems for tissue repair and regeneration.
    Vulic K; Shoichet MS
    Biomacromolecules; 2014 Nov; 15(11):3867-80. PubMed ID: 25230248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlled drug release for tissue engineering.
    Rambhia KJ; Ma PX
    J Control Release; 2015 Dec; 219():119-128. PubMed ID: 26325405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel therapeutic design of microporous-structured biopolymer scaffolds for drug loading and delivery.
    Dorj B; Won JE; Purevdorj O; Patel KD; Kim JH; Lee EJ; Kim HW
    Acta Biomater; 2014 Mar; 10(3):1238-50. PubMed ID: 24239677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering.
    Habraken WJ; Wolke JG; Jansen JA
    Adv Drug Deliv Rev; 2007 May; 59(4-5):234-48. PubMed ID: 17478007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neural tissue engineering: Bioresponsive nanoscaffolds using engineered self-assembling peptides.
    Koss KM; Unsworth LD
    Acta Biomater; 2016 Oct; 44():2-15. PubMed ID: 27544809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled drug delivery in tissue engineering.
    Biondi M; Ungaro F; Quaglia F; Netti PA
    Adv Drug Deliv Rev; 2008 Jan; 60(2):229-42. PubMed ID: 18031864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new method for the production of gelatin microparticles for controlled protein release from porous polymeric scaffolds.
    Ozkizilcik A; Tuzlakoglu K
    J Tissue Eng Regen Med; 2014 Mar; 8(3):242-7. PubMed ID: 22499408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug delivery in soft tissue engineering.
    Ladewig K
    Expert Opin Drug Deliv; 2011 Sep; 8(9):1175-88. PubMed ID: 21679089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controllable dual protein delivery through electrospun fibrous scaffolds with different hydrophilicities.
    Xu W; Atala A; Yoo JJ; Lee SJ
    Biomed Mater; 2013 Feb; 8(1):014104. PubMed ID: 23353662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Approaches to neural tissue engineering using scaffolds for drug delivery.
    Willerth SM; Sakiyama-Elbert SE
    Adv Drug Deliv Rev; 2007 May; 59(4-5):325-38. PubMed ID: 17482308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesenchymal stem cells and alginate microcarriers for craniofacial bone tissue engineering: A review.
    Saltz A; Kandalam U
    J Biomed Mater Res A; 2016 May; 104(5):1276-84. PubMed ID: 26826060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heart regeneration after myocardial infarction using synthetic biomaterials.
    Pascual-Gil S; Garbayo E; Díaz-Herráez P; Prosper F; Blanco-Prieto MJ
    J Control Release; 2015 Apr; 203():23-38. PubMed ID: 25665866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomimetic supramolecular designs for the controlled release of growth factors in bone regeneration.
    Azevedo HS; Pashkuleva I
    Adv Drug Deliv Rev; 2015 Nov; 94():63-76. PubMed ID: 26325686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymers, scaffolds and bioactive molecules with therapeutic properties in osteochondral pathologies: what's new?
    López-Ruiz E; Jiménez G; García MÁ; Antich C; Boulaiz H; Marchal JA; Perán M
    Expert Opin Ther Pat; 2016 Aug; 26(8):877-90. PubMed ID: 27337937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biofunctional materials for directing vascular development.
    Saik JE; McHale MK; West JL
    Curr Vasc Pharmacol; 2012 May; 10(3):331-41. PubMed ID: 22239635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-dimensionally engineered biomimetic tissue models for in vitro drug evaluation: delivery, efficacy and toxicity.
    Peck Y; Wang DA
    Expert Opin Drug Deliv; 2013 Mar; 10(3):369-83. PubMed ID: 23289593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic-designed electrospun bone scaffolds: mesoporous bioactive nanocarriers in hollow fiber composites to sequentially deliver dual growth factors.
    Kang MS; Kim JH; Singh RK; Jang JH; Kim HW
    Acta Biomater; 2015 Apr; 16():103-16. PubMed ID: 25617805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual-controlled release system of drugs for bone regeneration.
    Kim YH; Tabata Y
    Adv Drug Deliv Rev; 2015 Nov; 94():28-40. PubMed ID: 26079284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.